Follow the 원바이오젠 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 원바이오젠 has logged 15 insider filings. The latest transaction was filed on 21 November 2024 (Sale). Among the most active insiders: 교보증권. The full history is accessible without an account.
15
Insider Decl.
n/a
Thresholds
n/a
3 ops.
Buy Volume
n/a
11 ops.
Sell Volume
7Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.